Perceptive Advisors, a hedge fund firm well known for its public and private investments in life sciences and biopharma companies, is gearing up for the IPO of a company it actually founded.
LianBio, a Chinese company focused on developing in-licensed therapies for the Chinese and other Asian markets, plans to sell more than 20.3
